MXCT
Maxcyte·NASDAQ
--
--(--)
--
--(--)
4.55 / 10
Netural
Fund flow is strong, scoring 7.72/10 with positive inflows across all investor sizes. Analyst coverage is limited: 1 Buy, 2 Neutral, no sells, yielding a low weighted rating (1.39) and pessimistic market expectations. Capital is supportive, but sentiment remains cautious.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-07-22
InstitutionStephens & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for MXCT?
- MXCT holds a Bearish analyst rating, with 33% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.55/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
